We are live on
!
Find out more
First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
26 hedge funds and large institutions have $11.9M invested in First Trust Nasdaq Pharmaceuticals ETF in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
69% more capital invested
Capital invested by funds: $7.04M → $11.9M (+$4.87M)
37% more funds holding
Funds holding: 19 → 26 (+7)
10.73% more ownership
Funds ownership: 44.87% → 55.6% (+11%)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
Holders
26
Holders Change
+7
Holders Change %
+36.84%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$588K |
| 2 |
WFA
WMG Financial Advisors
Knoxville,
Tennessee
|
-$306K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$145K |
| 4 |
SC
Steph & Co
Marinette,
Wisconsin
|
-$142K |
| 5 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$13.3K |
